The transcription factors SOX2 and OCT3/4 were proposed as biomarkers for cell-type CSCs of cell lines and malignant tissues such as breast cancer (34, 35), human non–small cell lung cancer (11), bladder cancer, colon cancer, prostate cancer (36), and gastric cancer cells (37). The gene discussed is POU5F1; the disease is breast carcinoma.